scispace - formally typeset
N

Nicole L. Rosin

Researcher at University of Calgary

Publications -  34
Citations -  1235

Nicole L. Rosin is an academic researcher from University of Calgary. The author has contributed to research in topics: Wound healing & Medicine. The author has an hindex of 15, co-authored 24 publications receiving 810 citations. Previous affiliations of Nicole L. Rosin include University of British Columbia & Dalhousie University.

Papers
More filters
Journal ArticleDOI

Macrophages Regulate Schwann Cell Maturation after Nerve Injury.

TL;DR: It is demonstrated that after injury, including in humans, macrophages function to clear debris and persist within the nerve microenvironment and highlight a molecular mechanism by which this occurs.
Journal ArticleDOI

Imaging Collagen in Scar Tissue: Developments in Second Harmonic Generation Microscopy for Biomedical Applications.

TL;DR: An extensive review of studies that have used second harmonic generation imaging in skin, lung, cardiovascular, tendon and ligaments, and eye tissue to understand alterations in fibrillar collagens in scar tissue and the current methods of image analysis are reviewed.
Journal ArticleDOI

Distinct Regulatory Programs Control the Latent Regenerative Potential of Dermal Fibroblasts during Wound Healing

TL;DR: It is shown that hair follicle mesenchymal progenitors make limited contributions to wound repair, and pharmacological modulation of RUNX1 and retinoic acid signaling or genetic deletion of Hic1 within wound-activated fibroblasts was sufficient to modulate healing outcomes, suggesting that reparative fibro Blasts have latent but modifiable regenerative capacity.
Journal ArticleDOI

Chlamydia muridarum T-Cell Antigens Formulated with the Adjuvant DDA/TDB Induce Immunity against Infection That Correlates with a High Frequency of Gamma Interferon (IFN-γ)/Tumor Necrosis Factor Alpha and IFN-γ/Interleukin-17 Double-Positive CD4+ T Cells

TL;DR: A Chlamydia vaccine based on the recombinant proteins PmpG-1, PmpE/F-2, and MOMP delivered in a DDA/TDB adjuvant conferred protection against infection that correlated with IFN-γ/TNF-α and IFN -γ/IL-17 double-positive CD4+ T cells.